OraSure Technologies Current Ratio 2010-2025 | OSUR
OraSure Technologies current ratio from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| OraSure Technologies Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-03-31 | $0.31B | $0.03B | 12.34 |
| 2024-12-31 | $0.33B | $0.03B | 9.95 |
| 2024-09-30 | $0.35B | $0.03B | 12.60 |
| 2024-06-30 | $0.35B | $0.03B | 12.17 |
| 2024-03-31 | $0.35B | $0.03B | 11.97 |
| 2023-12-31 | $0.39B | $0.04B | 9.78 |
| 2023-09-30 | $0.36B | $0.04B | 8.71 |
| 2023-06-30 | $0.34B | $0.05B | 7.36 |
| 2023-03-31 | $0.34B | $0.06B | 6.23 |
| 2022-12-31 | $0.33B | $0.07B | 4.71 |
| 2022-09-30 | $0.28B | $0.07B | 3.90 |
| 2022-06-30 | $0.27B | $0.07B | 4.08 |
| 2022-03-31 | $0.27B | $0.06B | 4.83 |
| 2021-12-31 | $0.30B | $0.07B | 4.40 |
| 2021-09-30 | $0.29B | $0.05B | 5.34 |
| 2021-06-30 | $0.29B | $0.05B | 6.12 |
| 2021-03-31 | $0.29B | $0.05B | 6.55 |
| 2020-12-31 | $0.29B | $0.05B | 6.21 |
| 2020-09-30 | $0.30B | $0.04B | 8.14 |
| 2020-06-30 | $0.32B | $0.03B | 10.40 |
| 2020-03-31 | $0.22B | $0.03B | 8.48 |
| 2019-12-31 | $0.23B | $0.03B | 6.86 |
| 2019-09-30 | $0.22B | $0.03B | 7.72 |
| 2019-06-30 | $0.21B | $0.03B | 6.99 |
| 2019-03-31 | $0.21B | $0.03B | 7.52 |
| 2018-12-31 | $0.22B | $0.03B | 7.84 |
| 2018-09-30 | $0.21B | $0.02B | 9.71 |
| 2018-06-30 | $0.20B | $0.02B | 9.58 |
| 2018-03-31 | $0.20B | $0.02B | 9.29 |
| 2017-12-31 | $0.22B | $0.03B | 6.88 |
| 2017-09-30 | $0.21B | $0.03B | 7.86 |
| 2017-06-30 | $0.21B | $0.02B | 8.87 |
| 2017-03-31 | $0.18B | $0.02B | 9.88 |
| 2016-12-31 | $0.16B | $0.02B | 9.03 |
| 2016-09-30 | $0.15B | $0.02B | 6.87 |
| 2016-06-30 | $0.15B | $0.03B | 5.61 |
| 2016-03-31 | $0.13B | $0.02B | 6.60 |
| 2015-12-31 | $0.14B | $0.03B | 5.42 |
| 2015-09-30 | $0.14B | $0.03B | 4.78 |
| 2015-06-30 | $0.13B | $0.02B | 8.03 |
| 2015-03-31 | $0.12B | $0.02B | 7.03 |
| 2014-12-31 | $0.13B | $0.03B | 4.96 |
| 2014-09-30 | $0.13B | $0.03B | 5.15 |
| 2014-06-30 | $0.12B | $0.02B | 7.87 |
| 2014-03-31 | $0.11B | $0.02B | 7.47 |
| 2013-12-31 | $0.12B | $0.02B | 6.30 |
| 2013-09-30 | $0.11B | $0.02B | 5.76 |
| 2013-06-30 | $0.11B | $0.02B | 6.74 |
| 2013-03-31 | $0.11B | $0.02B | 6.28 |
| 2012-12-31 | $0.12B | $0.02B | 7.22 |
| 2012-09-30 | $0.12B | $0.02B | 7.27 |
| 2012-06-30 | $0.05B | $0.02B | 2.52 |
| 2012-03-31 | $0.05B | $0.02B | 2.61 |
| 2011-12-31 | $0.05B | $0.02B | 2.40 |
| 2011-09-30 | $0.05B | $0.02B | 2.34 |
| 2011-06-30 | $0.10B | $0.02B | 4.84 |
| 2011-03-31 | $0.09B | $0.02B | 5.17 |
| 2010-12-31 | $0.10B | $0.02B | 4.95 |
| 2010-09-30 | $0.10B | $0.02B | 5.26 |
| 2010-06-30 | $0.10B | $0.02B | 4.53 |
| 2010-03-31 | $0.10B | $0.01B | 8.48 |
| 2009-12-31 | $0.11B | $0.02B | 6.81 |
| 2009-09-30 | $0.11B | $0.01B | 7.60 |
| 2009-06-30 | $0.10B | $0.01B | 9.23 |
| 2009-03-31 | $0.10B | $0.01B | 8.98 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.210B | $0.186B |
| OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.034B | 28.02 |
| Boston Scientific (BSX) | United States | $152.131B | 38.08 |
| Stryker (SYK) | United States | $146.225B | 30.58 |
| EssilorLuxottica (ESLOY) | France | $128.281B | 0.00 |
| Medtronic (MDT) | Ireland | $111.581B | 15.82 |
| Haleon (HLN) | United Kingdom | $50.069B | 28.51 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.244B | 0.00 |
| ResMed (RMD) | United States | $36.611B | 27.50 |
| GE HealthCare Technologies (GEHC) | United States | $32.762B | 15.55 |
| Agilent Technologies (A) | United States | $32.366B | 21.10 |
| Terumo (TRUMY) | Japan | $26.576B | 34.52 |
| Insulet (PODD) | United States | $22.320B | 87.61 |
| Koninklijke Philips (PHG) | Netherlands | $21.929B | 15.76 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.186B | 11.68 |
| Baxter (BAX) | United States | $15.472B | 11.55 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.270B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.449B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $5.968B | 20.77 |
| Lantheus Holdings (LNTH) | United States | $5.558B | 14.02 |
| Prestige Consumer Healthcare (PBH) | United States | $4.181B | 18.68 |
| Perrigo (PRGO) | Ireland | $3.570B | 9.05 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.382B | 15.40 |
| ICU Medical (ICUI) | United States | $3.271B | 24.12 |
| Envista Holdings (NVST) | United States | $3.166B | 26.31 |
| GN Store Nord (GNNDY) | Denmark | $2.180B | 18.06 |
| QuidelOrtho (QDEL) | United States | $2.022B | 13.91 |
| LeMaitre Vascular (LMAT) | United States | $1.884B | 42.12 |
| AtriCure (ATRC) | United States | $1.726B | 0.00 |
| Acuren (TIC) | United States | $1.272B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.217B | 12.36 |
| Green Thumb Industries (GTBIF) | United States | $1.080B | 24.29 |
| Neogen (NEOG) | United States | $1.066B | 13.64 |
| Kestra Medical Technologies (KMTS) | United States | $1.025B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.021B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.968B | 12.38 |
| InMode (INMD) | Israel | $0.906B | 9.13 |
| CeriBell (CBLL) | United States | $0.633B | 0.00 |
| Evolus (EOLS) | United States | $0.628B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.602B | 0.00 |
| Owens & Minor (OMI) | United States | $0.588B | 4.88 |
| Curaleaf Holdings (CURLF) | Canada | $0.565B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.553B | 0.00 |
| Valneva SE (VALN) | France | $0.525B | 0.00 |
| Surmodics (SRDX) | United States | $0.426B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.391B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.345B | 12.68 |
| SNDL (SNDL) | Canada | $0.339B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.304B | 54.10 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.291B | 0.00 |
| Cerus (CERS) | United States | $0.264B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.260B | 21.97 |
| Cresco Labs (CRLBF) | United States | $0.260B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.257B | 0.00 |
| ZimVie (ZIMV) | United States | $0.254B | 11.54 |
| Canopy Growth (CGC) | Canada | $0.252B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.238B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.202B | 0.00 |
| Biote (BTMD) | United States | $0.201B | 5.65 |
| Quanterix (QTRX) | United States | $0.200B | 0.00 |
| Brainsway (BWAY) | Israel | $0.195B | 51.55 |
| Omeros (OMER) | United States | $0.193B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.191B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.182B | 14.82 |
| Organigram Global (OGI) | Canada | $0.175B | 0.00 |
| Exagen (XGN) | United States | $0.153B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 16.72 |
| Vireo Growth (VREOF) | United States | $0.127B | 0.00 |
| Jin Medical (ZJYL) | China | $0.124B | 0.00 |
| MacroGenics (MGNX) | United States | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.60 |
| Veru (VERU) | United States | $0.088B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.087B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.084B | 0.00 |
| Agape ATP (ATPC) | $0.073B | 0.00 | |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.066B | 0.00 |
| Zynex (ZYXI) | United States | $0.064B | 0.00 |
| Apyx Medical (APYX) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.058B | 0.00 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.02 |
| Nephros (NEPH) | United States | $0.036B | 48.57 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Safety Shot (SHOT) | United States | $0.019B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.015B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |